HIV+ MALT lymphoma remission induced by highly active antiretroviral therapy alone.
MALT lymphoma is usually described in association with Helicobacter pylori, HCV, HHV8, Campylobacter jejuni or in a setting of overreactive immunity. In HIV(+) patients, MALT lymphoma is most commonly described in children. We describe here an original case of HIV(+) MALT lymphoma with bronchial, conjuctival and laryngeal involvement for which a clinical and histopathological remission has been obtained with HAART alone. We conclude that HIV, as well as H. pylori, C. jejuni and HCV can target lymphogenesis in MALT lymphoma.
Girard
Thomas
T
Service de Mèdecine Interne, Hôpital Béclère, Clamart, France. thomas.girard@cch.ap-hop-paris.fr
Luquet-Besson
Isabelle
I
Baran-Marszak
Fanny
F
Raphaël
Martine
M
Boué
François
F
D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D015322:Gene Rearrangement, B-Lymphocyte; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology / Q000473:pathology; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D008875:Middle Aged; D012074:Remission Induction